Cargando…
Mitochondrial complex II and reactive oxygen species in disease and therapy
Increasing evidence points to the respiratory Complex II (CII) as a source and modulator of reactive oxygen species (ROS). Both functional loss of CII as well as its pharmacological inhibition can lead to ROS generation in cells, with a relevant impact on the development of pathophysiological condit...
Autores principales: | Hadrava Vanova, Katerina, Kraus, Michal, Neuzil, Jiri, Rohlena, Jakub |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7178880/ https://www.ncbi.nlm.nih.gov/pubmed/32290794 http://dx.doi.org/10.1080/13510002.2020.1752002 |
Ejemplares similares
-
Reactive Oxygen Species: A Promising Therapeutic Target for SDHx-Mutated Pheochromocytoma and Paraganglioma
por: Hadrava Vanova, Katerina, et al.
Publicado: (2021) -
MitoTam-01 Trial: Mitochondrial Targeting as Plausible Approach to Cancer Therapy. Comment on Yap et al. Complex I Inhibitor of Oxidative Phosphorylation in Advanced Solid Tumors and Acute Myeloid Leukemia: Phase I Trials. Nat. Med. 2023, 29, 115–126
por: Neuzil, Jiri, et al.
Publicado: (2023) -
High Molecular Weight Forms of Mammalian Respiratory Chain Complex II
por: Kovářová, Nikola, et al.
Publicado: (2013) -
PD-L1 expression and association with genetic background in pheochromocytoma and paraganglioma
por: Hadrava Vanova, Katerina, et al.
Publicado: (2022) -
Mitochondria on the move: Horizontal mitochondrial transfer in disease and health
por: Dong, Lan-Feng, et al.
Publicado: (2023)